The role of adiponectin in cancer: a review of current evidence
M Dalamaga, KN Diakopoulos… - Endocrine …, 2012 - academic.oup.com
Improving physical function and mobility in a continuously expanding elderly population
emerges as a high priority of medicine today. Muscle mass, strength/power, and maximal …
emerges as a high priority of medicine today. Muscle mass, strength/power, and maximal …
The bone marrow microenvironment in B-cell development and malignancy
Simple Summary B cells are an essential component of the immune system and develop in
the bone marrow microenvironment. B-cell development is tightly regulated by the stromal …
the bone marrow microenvironment. B-cell development is tightly regulated by the stromal …
[HTML][HTML] Evolving role of adiponectin in cancer-controversies and update
A Katira, PH Tan - Cancer biology & medicine, 2016 - ncbi.nlm.nih.gov
Adiponectin (APN), an adipokine produced by adipocytes, has been shown to have a critical
role in the pathogenesis of obesity-associated malignancies. Through its receptor …
role in the pathogenesis of obesity-associated malignancies. Through its receptor …
Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia
ES Tonorezos, GL Vega, CA Sklar… - Pediatric blood & …, 2012 - Wiley Online Library
Background Following our previous reports of an increased prevalence of insulin resistance
and adiposity among acute lymphoblastic leukemia (ALL) survivors, particularly women …
and adiposity among acute lymphoblastic leukemia (ALL) survivors, particularly women …
Role for leptin and leptin receptors in stem cells during health and diseases
T Trinh, HE Broxmeyer - Stem Cell Reviews and Reports, 2021 - Springer
Hematopoietic stem cells (HSCs) give rise to all blood and immune cells in the body. These
rare cells reside in the hypoxic niche of the bone marrow (BM) where they are subjected to a …
rare cells reside in the hypoxic niche of the bone marrow (BM) where they are subjected to a …
[HTML][HTML] Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies
T Wei, P Ye, X Peng, LL Wu, GY Yu - Oncotarget, 2016 - ncbi.nlm.nih.gov
Early detection of cancers is challenging for lack of specific biomarkers. Adiponectin is an
adipokine predominantly derived from adipocytes and hypoadiponectinemia has been …
adipokine predominantly derived from adipocytes and hypoadiponectinemia has been …
Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives
M Dalamaga - Biomarkers in medicine, 2014 - Taylor & Francis
Excess body weight is associated with various types of malignancies. Resistin, originally
described as an adipocyte-specific hormone modulating insulin resistance in rodents, may …
described as an adipocyte-specific hormone modulating insulin resistance in rodents, may …
The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia
X Sheng, SD Mittelman - Frontiers in pediatrics, 2014 - frontiersin.org
Obesity is responsible for~ 90,000 cancer deaths/year, increasing cancer incidence and
impairing its treatment. Obesity has also been shown to impact hematological malignancies …
impairing its treatment. Obesity has also been shown to impact hematological malignancies …
[HTML][HTML] Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy
Accumulating evidences have shown that adipokines secreted from adipocytes contributes
to tumor development, especially leptin. However, underlying mechanisms remain unclear …
to tumor development, especially leptin. However, underlying mechanisms remain unclear …
Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies
M Dalamaga, GS Christodoulatos - Hormone molecular biology and …, 2015 - degruyter.com
Higher body mass index and adiposopathy have been associated with increased risk of
hematologic malignancies such as leukemia, multiple myeloma, myeloproliferative …
hematologic malignancies such as leukemia, multiple myeloma, myeloproliferative …